- Abstract Number: 1752
T Cell-Engaging Bispecific Antibodies to Target Autoreactive 9G4 Idiotope B Cells in Systemic Lupus Erythematosus
- Abstract Number: 1784
T-bet Expressing B Cells as a Putative Prognostic and Therapeutic Biomarker for Human SLE
- Abstract Number: 0251
T-SPOT.TB and TST in Diagnosing Active Tuberculosis in Patients with Rheumatic Immune Diseases: A Fully Paired Comparative Diagnostic Test Accuracy Study
- Abstract Number: 1300
Tackling Rheumatology Workforce Shortages with a Case-Based Primary Care Rheumatology Curriculum
- Abstract Number: L01
Targeted Exosite Inhibition of STING Activation of TBK1 Selectively Blocks Type I Interferon and NFκB Responses for Treatment of Autoimmune Diseases
- Abstract Number: 0875
Targeted IL-15 Muteins Provide Selective Expansion of KIR+ CD8 Regulatory T Cells, with the Potential to Ameliorate Disease in Autoimmune Patients with Deficient CD8 Treg Populations
- Abstract Number: 0040
Targeting Complement Factor B (CFB) via a Novel siRNA Therapy (AZD6912) to Treat Inflammatory Arthritis
- Abstract Number: 0944
Targeting Defective Macrophages to Restore Resolution of Inflammation in Rheumatoid Arthritis -Perspectives for an Autologous Secretome Therapy
- Abstract Number: 0091
Targeting Endothelial Dysfunction in Lupus Nephritis: Effect of Sepiapterin, a Drug That Restores Endothelial Nitric Oxide Synthase Function, in a Murine Model of Lupus Nephritis
- Abstract Number: 1832
Targeting Hippo Pathway Diminishes Disease Signaling in Scleroderma Skin
- Abstract Number: 0275
Targeting IRAK4 in Monosodium Urate Crystals Induced Inflammation
- Abstract Number: 1860
Targeting Th1 Effector Cytokines, TNF-α and IFN-γ, Attenuates Experimental Autoimmune Myeloperoxidase ANCA Associated Vasculitis
- Abstract Number: 0958
TCR Motifs Identify Unique Clones in African Americans with Systemic Sclerosis
- Abstract Number: 1854
TCR-Nck Modulators: Pioneering Oral Modulation of T Cell Receptor Activation Holding the Promise of Treating Autoimmune Diseases
- Abstract Number: 2574
Tear Biomarkers for Monitoring Disease Activity and Progression of Noninfectious Chronic Anterior Uveitis in Children
- Abstract Number: 1781
Tear Proteomics as a Classifier of Disease Type and Activity Status in Pediatric Uveitis
- Abstract Number: 1950
Telehealth Physical Therapy Intervention to Increase Physical Activity in Adults with Knee OA: The Delaware PEAK Randomized Controlled Trial
- Abstract Number: 1933
Telemedicine for Under-resourced Patients with Systemic Lupus Erythematosus: A Qualitative Study Exploring the Views and Experiences of Patients and Rheumatology Health Care Professionals
- Abstract Number: 2539
Telocytes Integrated into Mast Cells and Joint-Draining Lymphatic Vessels Potentially Regulate Lymphatic Clearance
- Abstract Number: 2343
Temporal Trends in and Associations with NSAID Prescription in Adult and Pediatric Patients with IBD
- Abstract Number: 1397
Temporal Trends in Early Rheumatoid Arthritis (ERA) Patients with Moderate to Severe Disease Activity: A Multicenter Cohort Study of Treatment Strategies and Outcomes in Chinese Patients in the Modern Era
- Abstract Number: 1595
Tezepelumab for Relapsing or Refractory Eosinophilic Granulomatosis with Polyangiitis: A European Retrospective Study
- Abstract Number: 2595
TGF-β Activated Kinase 1 (TAK1) Inhibition Suppresses Synovial Inflammation and Tissue Destruction Mediated by Activated Juvenile Idiopathic Arthritis Synovial Fibroblasts
- Abstract Number: 0920
TGF-β Activated Kinase 1 Inhibition by Pentagalloyl Glucose Inhibits NLRP3 Inflammasome Formation and Ameliorates MSU-Induced Inflammation
- Abstract Number: 2301
The Added Value of anti-Ro52 Antibody Titer in the Diagnosis of Sjögren’s Disease
- Abstract Number: 1237
The Art of Choosing Together: Unveiling the Patient’s Perspective in Rheumatology
- Abstract Number: 0819
The Assessment of SpondyloArthritis International Society (ASAS) Definition of Difficult-to-Manage Axial Spondyloarthritis
- Abstract Number: 0072
The Association Between Activation of Inflammasome and HLA-B27 in Dendritic Cells of Patients with Axial Spondyloarthritis
- Abstract Number: 2180
The Association Between Age at Diagnosis and Patient-Reported Outcomes in Patients with Vasculitis
- Abstract Number: 2237
The Association Between Bariatric Surgery and Incident Rheumatoid Arthritis
- Abstract Number: 0388
The Association Between Body Composition and Disease and Treatment Outcomes in Patients with Juvenile Idiopathic Arthritis: Results from the CAPRI Registry
- Abstract Number: 0133
The Association Between Gout and Gallstone Disease: US General Population Analysis
- Abstract Number: 0913
The Association Between PTPN2 and Leukopenia in New Users of Azathioprine
- Abstract Number: 1325
The Association Between the Number of Teeth and All-Cause as Well as Cardiovascular Mortality Among Patients with RA: NHANES from 1999 to 2004
- Abstract Number: 2203
The Association of Autoantibodies with Clinical Manifestations and Long-term Outcomes in Juvenile- and Adult-onset Systemic Sclerosis
- Abstract Number: 1436
The Association of Cigarette Smoking with Radiographic Progression in Psoriatic Arthritis
- Abstract Number: 1354
The Association of Genetic Variation in PTPN22 and Rheumatoid Arthritis Disease Activity
- Abstract Number: 1335
The Association of Patient-Reported Non-Articular Pain with Musculoskeletal Pain Diagnoses and RA Disease Activity in a Prospective Real-World Cohort of Patients with Early RA
- Abstract Number: 1583
The Association of Weakpositive Anti-RNA Polymerase III Antibodies with the Diagnosis and Complications of Systemic Sclerosis and Other Systemic Autoimmune Diseases
- Abstract Number: 1352
The Associations Between Genetic Factors and Rheumatoid Arthritis Treatment Patterns: Data from Two Large Healthcare Systems
- Abstract Number: 1878
The Associations Between Gout and Ischemic Colitis Among Hospitalized Patients: A Retrospective Nationwide Analysis
- Abstract Number: 0081
The Axial Spondyloarthritis Risk Variant CARD9 S12N Enhances Neutrophil-mediated Th Responses
- Abstract Number: 1281
The Brazilian Registry of Juvenile Dermatomyositis: Relationship Between Ultraviolet Radiation and Laboratory Markers of Juvenile Dermatomyositis in a Tropical Country
- Abstract Number: 1945
The Bridge to Adult Care from Childhood for Young Adults with Rheumatic Disease (BACC YARD) Program, a Pediatric-to-Adult Rheumatology Transition Program: 2024 Updates
- Abstract Number: 0981
The Causal Effect of Sex Hormone-related Drugs on the Risk of Osteoarthritis – A Mendelian Randomization Study
- Abstract Number: 0150
The Characteristics of a Northern Israeli Cohort of Patients with Behcet’s Syndrome
- Abstract Number: L07
The Classification Criteria for Anti-Synthetase Syndrome (Class) Project
- Abstract Number: 0820
The Classification in Axial Spondyloarthritis Inception Cohort Study: Performance of the 2009 Assessments in Spondyloarthritis International Society Classification Criteria
- Abstract Number: 2443
The Clinical Phenotype of Anti-Th/To+ Patients in Systemic Sclerosis: A Case-control Study Within the European Scleroderma Trials and Research (EUSTAR) Cohort
- Abstract Number: 0424
The Clinical Utility of Serum BAFF Levels in Pregnant Patients with SLE
- Abstract Number: 0930
The Common Form of the Inflammatory Skin Disease Hidradenitis Suppurativa Is Associated with Low Nicastrin Expression in Dermal Fibroblasts
- Abstract Number: 2373
The Construction and Validation of Sub-phenotype-specific Genetic Risk Scores in Systemic Lupus Erythematosus: A Novel Approach Using Large-scale Biobank Data
- Abstract Number: 1101
The Contemporary Prevalence of Comorbid Gout and Chronic Kidney Disease, Two Common Conditions with High Morbidity, in the US General Population
- Abstract Number: 1050
The Cost-effectiveness of Glucagon-Like Peptide-1 Receptor Agonists (GLP1RAs) for Patients with Knee Osteoarthritis and Obesity
- Abstract Number: 2475
The Critical Role of Annual HRCT in Identifying ILD Progression and Assessing Outcome in SSc
- Abstract Number: 0924
The Cytosolic DNA Sensor AIM2 Regulates Bone Homeostasis Through Bone Progenitor Cell Differentiation
- Abstract Number: 0863
The Development of Future Radiographic Knee Osteoarthritis Can Be Predicted by Peripheral Blood Epigenetic Models
- Abstract Number: 2030
The Development of the EULAR Score for the Definition of Disease Activity in Adult-onset Still’s Disease; The “DAVID” Project
- Abstract Number: 0684
The Diagnostic Accuracy of Ultrasound for Low Muscle Mass in Women with Systemic Sclerosis
- Abstract Number: 2268
The Discontinuation and Effectiveness of Sequential Advanced Therapy in Rheumatoid Arthritis, a Real-World Data
- Abstract Number: 2021
The Dual Benefits of Sodium-Glucose Cotransporter-2 Inhibitors for Recurrent Nephrolithiasis and Gout Flares Among Gout Patients with Type 2 Diabetes: New User, Active Comparator Target Trial Emulation Studies
- Abstract Number: 0555
The Effect of Alcohol Consumption on Clinical Outcomes and Structural Damage in Patients with Axial Spondyloarthritis: A Systematic Literature Review and Meta-Analysis
- Abstract Number: 2323
The Effect of Biologic Therapies on Serum Metabolic Biomarkers in Patients with Psoriatic Arthritis
- Abstract Number: 0421
The Effect of Biologic Treatment for Psoriatic Arthritis and Axial Spondyloarthritis on Semen Parameters – a Longitudinal Study
- Abstract Number: 2510
The Effect of Coronary Artery Aneurysms and IVIG Use on Long-term Cardiovascular Disease and Mortality Following Kawasaki Disease in Childhood: A Systematic Review and Meta-analysis
- Abstract Number: 1361
The Effect of Disease Activity on Cardiovascular Risk Varies According to Rheumatoid Factor and Anticitrullinated Protein Antibody Status in Patients with Rheumatoid Arthritis
- Abstract Number: 2238
The Effect of Inflammation on Cardiovascular Risk in Rheumatoid Arthritis Varies According to Sex and Anticitrullinated Protein Antibody Status
- Abstract Number: 0824
The Effect of Intranasal Niclosamide on Nasal Symptoms in Patients with ENT Manifestations of ANCA-Associated Vasculitis (AAV): Post Hoc Analysis of Subset of Patients Recruited to the PROTECT-V Trial
- Abstract Number: 1373
The Effect of Methotrexate on Lipid and Apolipoprotein Levels in RA Goes Hand-in-hand with EULAR Response
- Abstract Number: 0141
The Effect of Systemic Immunosuppressive Therapies on Cardiovascular Risk in Psoriatic Arthritis Patients
- Abstract Number: 1183
The Effectiveness of Orthosis for the Management of Hand Osteoarthritis-a Systemic Review and Meta-analysis
- Abstract Number: 0919
The Effects of CB2R Activation on Inflammatory Pathways in Dermatomyositis
- Abstract Number: 2592
The Effects of Early Life Trauma and Socioeconomic Position on Systemic Lupus Erythematosus Risk in Adulthood
- Abstract Number: 1278
The Effects of Fatigue on Self-Reported Mental and Physical Health in Childhood-Onset Systemic Lupus Erythematosus: A Cross-Sectional Study
- Abstract Number: 2085
The Effects of Pioglitazone on Metabolic Dysregulation in Inclusion Body Myositis: An Open-Label Pilot Study
- Abstract Number: 0129
The Efficacy and Safety of Telitacicept Following Rituximab Immunotherapy on Antiphospholipid Syndrome, a Prospective 24- Week Study
- Abstract Number: 0960
The Esophageal Epithelium in Systemic Sclerosis: Cellular and Molecular Dysregulation Revealed by Single-Cell RNA Sequencing
- Abstract Number: 1672
The Evaluation of SLE Outcome Measures in Telemedicine
- Abstract Number: 2186
The Exploration of Secondary Amplified Musculoskeletal Pain Syndrome (AMPS) in Pediatric Patients with Rheumatologic Disease
- Abstract Number: 2682
The Forgotten Costs of SLE: Estimating Indirect Costs in a National SLE Cohort
- Abstract Number: 1447
The Frequency of Diffuse Idiopathic Skeletal Hyperostosis (DISH) in Spondyloarthritis in Comparison to Age and Sex-matched Controls and Impact of SpA on Onset Age of DISH
- Abstract Number: 0477
The Global Prevalence of Interstitial Lung Disease in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-analysis
- Abstract Number: 0097
The Human Lupus TREX1 D18N Mutation Engineered in C. Elegans Leads to Cell Death. What Can We Learn About Lupus Using C. Elegans?
- Abstract Number: 2105
The Identity, Impact, and Management of OA and OA Pain from the Perspective of People with OA: A Systematic Literature Review of Qualitative Studies
- Abstract Number: 1257
The Immune and Growth Characteristics of Children Born to Mothers with Systemic Lupus Erythematosus
- Abstract Number: 1811
The Immune Map of Lupus Nephritis: A Spatially Resolved Kidney Proteomic Approach
- Abstract Number: 2416
The Impact of Active Lupus Nephritis on Work Productivity in Patients from a Latin American Lupus Cohort
- Abstract Number: 0870
The Impact of Body Mass Index on Cardiovascular Risk in Rheumatoid Arthritis Varies Across Anticitrullinated Protein Antibody Status and Biologic Use
- Abstract Number: 1974
The Impact of Concomitant Shoulder Osteoarthritis in Polymyalgia Rheumatica
- Abstract Number: 0245
The Impact of COVID-19 and ‘Long COVID’ on Self-Reported Disease Activity, Disability, and Quality of Life in Patients with Inflammatory Arthritis
- Abstract Number: 1254
The Impact of Eosinophilic Granulomatosis with Polyangiitis on the Health-Related Quality of Life of Patients and Their Ability to Work: Evidence from a Real-World Survey in Clinical Practice
- Abstract Number: 0142
The Impact of Hospital Region on Mortality and Other Outcomes in Patients with Gout: A Two-Year Nationwide Analysis
- Abstract Number: 2508
The Impact of Lipid Profile Parameters on the Incidence of Major Adverse Cardiovascular Events in Rheumatoid Arthritis Patients: A Single-arm Meta-Analysis
- Abstract Number: 0325
The Impact of Polymyositis and Dermatomyositis in Patients Hospitalized with Inflammatory Bowel Disease: A Nationwide Inpatient Database Analysis
- Abstract Number: 1019
The Impact of Race and Ethnicity and Historical Redlining on Psoriatic Disease Burden
- Abstract Number: 1285
The Impact of Race and Social Determinants of Health on Patient Reported Outcomes in Pediatric Lupus: A CARRA Registry Study
- Abstract Number: 1313
The Impact of Rheumatology Fellow Initiated Curriculum Design on Resident Education for R1 versus R2-R4 Learners
- Abstract Number: 0123
The Impact of Sedentary Behavior and Physical Activity Level on Clinical Parameters and Quality of Life in Patients with Primary Antiphospholipid Syndrome (PAPS)
- Abstract Number: 2476
The Impact of Systemic Sclerosis Manifestations on Survival and Humanistic Burden: A Targeted Literature Review
- Abstract Number: 0030
The Impact of Treadmill Exercise on Various Stages of Osteoarthritis Progression in a Murine Osteoarthritis Model
- Abstract Number: 0148
The Incidence and Prevalence of Sarcoidosis in England
- Abstract Number: 1095
The Incidence of Gout Among Individuals with Hyperuricemia over Time – an Insight from a Nationwide Cohort Study
- Abstract Number: 0842
The Incident Risk and Predictors of Systemic Autoimmune Rheumatic Disease (SARD) Development in Persistently Antiphospholipid Antibody Positive Patients Without SARDs: Prospective Results from the APS ACTION Clinical Database and Repository (“Registry”)
- Abstract Number: 1520
The Influence of Trauma on Features of Type 2 SLE
- Abstract Number: 2010
The Influence of Treat-to-target Urate Lowering Therapy and Anti-inflammatory Prophylaxis on Circulating Measures of Inflammation in Gout
- Abstract Number: 0979
The Joint Project: A Community-Based, Barangay Health Worker-Led Screening Program for Childhood Musculoskeletal Disorders in a Barangay in San Pedro, Laguna, Philippines
- Abstract Number: 1082
The Journey of a Patient with Psoriatic Arthritis: The Path from Diagnosis to Treatment
- Abstract Number: 2535
The Lipidomic and Proteomic Profiles in Antiphospholipid Syndrome Patients Are Intricately Linked to Disease Pathogenesis and Modulated by Ubiquinol Supplementation
- Abstract Number: 0569
The Longitudinal Association Between Disease Activity, Function and Health-Related Quality of Life in Axial Spondyloarthritis: Results from the DESIR Cohort
- Abstract Number: 0838
The Mechanistic Impact of IgA anti-beta-2 Glycoprotein I on Accelerated Atherosclerosis in Primary APS
- Abstract Number: 0609
The Mediating Role of Trust in Usual Rheumatologists on the Relationship Between Multidimensional Health Literacy and Medication Adherence Among Japanese Systemic Lupus Erythematosus Patients
- Abstract Number: 2498
The Methylome Profile of B-cells as a Biomarker of Nephritis in IgA Vasculitis
- Abstract Number: 1953
The National Trend of Using Prescription Immunosuppressives
- Abstract Number: 2413
The Natural History of SLE Has Changed Since the 1970s
- Abstract Number: 1108
The Needed Daily Dose of Colchicine in Patients with Familial Mediterranean Fever May Be Higher in Women, a Study on Behalf of the JIR Cohort
- Abstract Number: 1059
The Negative Impact of Physicians’ Neuroticism and Conscientiousness on Shared Decision Making in Patients with Systemic Lupus Erythematosus: The TRUMP2-SLE Project
- Abstract Number: 0854
The OMERACT GCA Phantom Project: Validation of 3D Printed Ultrasound Training Models for Giant Cell Arteritis
- Abstract Number: 1126
The Outcomes of Carpal Tunnel Injections and Carpal Tunnel Surgery
- Abstract Number: 2514
The Pattern of Renal Involvement in Relapsing Cryoglobulinemic Vasculitis After Successful Sustained Viral Response by Direct-Acting Antiviral Treatments
- Abstract Number: 1118
The Performance of Behcet’s Disease Clinical Diagnostic Criteria in a Low Prevalence Region. A Retrospective Single Center Cohort Study
- Abstract Number: 0840
The Platelet Adenosinergic Axis as a Novel Therapeutic Target for Thrombotic APS
- Abstract Number: 2263
The Potential Use of Circulating Extracellular Vesicles for Improved Diagnosis and Therapy in Rheumatic Inflammatory/autoimmune Diseases: Proof of Concept Studies
- Abstract Number: 0222
The Prediction of Response to Advanced Therapies on a Joint Level in Rheumatoid Arthritis: The Interpretation of Tenderness and Doppler Ultrasound
- Abstract Number: 1896
The Prevalence, Incidence, Risk Factors and Time to Diagnosis of Behcet’s Syndrome in England: A Retrospective Nested Case Control Study in Clinical Practice Research Datalink and Hospital Episode Statistics
- Abstract Number: 0137
The Problem of Pain in Rheumatology: Sociodemographic and Disease-related Correlates of Agreement Between Structured Data Elements and Clinical Notes in Chronic Pain Documentation Practices in EHR
- Abstract Number: 1226
The Problem of Pain in Systemic Lupus Erythematosus: A Comprehensive Analysis of Pain Distribution Using the CHOIR Body Map and PROMIS Measures
- Abstract Number: 1448
The Proportion of Inflammatory Back Pain Patients with an Abnormal Sacral MRI in a Community-Based Primary Care Setting
- Abstract Number: 2557
The Relation of Colchicine to Knee/hip Replacement Among People with Gout in a Population-based Cohort Study
- Abstract Number: 1195
The Relations of Analgesic Antidepressants Use to Knee or Hip Replacement Among Osteoarthritis Patients Compared to Selective Serotonin Reuptake Inhibitors in a Large Prospective Cohort
- Abstract Number: 2011
The Relationship Between Anti-drug Antibodies, Infusion Reactions, and Loss of Urate-lowering Response in Patients with Uncontrolled Gout Treated with Pegloticase
- Abstract Number: 1262
The Relationship Between Child Opportunity Index and Burden of Pediatric Systemic Lupus Erythematosus
- Abstract Number: 2398
The Relationship Between First-Trimester Maternal Serum 25-Hydroxyvitamin D and Maternal/Fetal Outcomes in Patients with Systemic Lupus Erythematosus
- Abstract Number: 1586
The Relationship Between the Presence, Quantity and Distribution of Cutaneous Telangiectasia and Other Vascular Manifestations of Systemic Sclerosis
- Abstract Number: 2104
The Relationship of Soluble Biomarkers to OA Pain: A Systematic Literature Review
- Abstract Number: 2291
The Relationship of the ESSDAI to Health-Related Quality of Life in People Living with Sjogren’s Disease
- Abstract Number: 0318
The Relevance of a Positive ANA in New Patient Referrals to Rheumatology
- Abstract Number: 1685
The Renal Activity Index for Lupus (RAIL) Identifies Active Renal Disease in SLE Patients and Its Longitudinal Score Associates with Achievement of Renal Responses in Lupus Nephritis
- Abstract Number: 1948
The Rheumatology Physician Assistant/Associate Workforce
- Abstract Number: 2666
The Risk for Development of Myositis Is Not Increased After COVID-19 Vaccination Among U.S. Veterans
- Abstract Number: 2264
The Risk of Malignancy and Major Adverse Cardiovascular Events with the Use of Janus Kinase Inhibitors in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis of Real-World Evidence
- Abstract Number: 2117
The Risk of Medication-related Osteonecrosis of the Jaw (MRONJ) in a Patient with Osteoporosis Treated with Antiresorptive Therapy and Undergoing Dental Care Is Negligible with a CTX Threshold Above 260
- Abstract Number: 0564
The Risk of Venous Thromboembolism in Axial Spondyloarthritis: A Population-based Study
- Abstract Number: 0038
The Role of Dual Specificity Phosphatase 22 (DUSP22) in Rheumatoid Arthritis: Mechanism and Genetic Investigations
- Abstract Number: 0686
The Role of Inflammation in Systemic Sclerosis: CRP-Associated Phenotypes and Prognostic Implications
- Abstract Number: 2371
The Role of Intracytoplasmic Toll- Like Receptors (TLR) and MyD88 in B Cell Subsets as Renal Response Predictors in Patients with Lupus Nephritis
- Abstract Number: 1103
The Role of Renal Dual-Energy CT in Exploring the Gouty Kidney: The RENODECT Study
- Abstract Number: 2059
The Rs35705950 Promoter Variant of Muc5b Is Associated with Usual Interstitial Pneumonia in Antisynthetase Syndrome
- Abstract Number: 0221
The Significance of Tenderness with or Without Swelling of Finger Joints in Relation to Magnetic-resonance-imaging, Ultrasound and X-ray in Psoriatic Arthritis
- Abstract Number: 2597
The Stromal-cell Derived Cytokine interleukin-17D Attenuates Joint Inflammation
- Abstract Number: 0883
The Study of 62 Circulating Soluble Factors Is Able to Predict the Lack of Response to MTX Treatment in Recently Diagnosed DMARD Naïve Rheumatoid Arthritis Smoker and Non-Smoker Patients
- Abstract Number: 1502
The Systemic Lupus International Collaborating Clinics (SLICC) Frailty Index (SLICC-FI) Predicts Hospitalizations. Data from the Almenara Lupus Cohort
- Abstract Number: 0487
The Triglyceride to HDL Ratio, a Surrogate Marker of Insulin Resistance, Predicts All Cause and Cardiovascular Mortality in Rheumatoid Arthritis
- Abstract Number: 2235
The Updated PREVENT (Predicting Risk of CVD EVENTs) Algorithm Is Not Able to Indicate Subclinical Coronary or Carotid Atherosclerosis Better Than the Traditional Pooled Cohort Equations in Rheumatoid Arthritis
- Abstract Number: 1465
The Use of Disease Activity Thresholds for the Psoriatic Arthritis Impact of Disease Questionnaire to Assess Patient Perceptions of Disease Burden in Patients with Early Oligoarticular Psoriatic Arthritis Treated with Apremilast in a Phase 4 Trial
- Abstract Number: 0312
The Use of Electromyography as a Screening Tool in Sarcoidosis-associated Neuropathy
- Abstract Number: 0809
The Utility of the sFlt1:PlGF Ratio to Rule out and Predict Preeclampsia in Women with Lupus
- Abstract Number: 2296
The Value of Ultrasound to Follow Glandular Disease in Sjogren’s Disease Patients
- Abstract Number: 2258
The Window of Opportunity: A Concept Also Applicable to Undifferentiated Arthritis
- Abstract Number: 2687
Therapeutic Choices in Systemic Sclerosis Associated Interstitial Lung Disease, a Survey of International Experts
- Abstract Number: 0714
Therapeutic Dilemmas in Patients with ANCA-associated Vasculitis: Diffuse Alveolar Hemorrhage, Venous Thromboembolism and Anticoagulation
- Abstract Number: 1276
Therapeutic Drug Monitoring (TDM) of Rituximab to Predict Early B-Cell Repopulation in Children
- Abstract Number: 0465
Therapeutic Drug Monitoring of the Adalimumab Biosimilar (AMJEVITA™, Adalimumab-atto) Using Originator Adalimumab and Anti-Adalimumab Antibody Assays
- Abstract Number: 1060
Therapeutic Hydroxychloroquine Blood Levels Predict Lower Mean Frequency of Recurrent Acute Care Utilization in Lupus
- Abstract Number: 2028
Therapeutic Insights in VEXAS Syndrome from a Multicenter Study in Spain: Moving Towards Amore Specific and Effective Treatment
- Abstract Number: 0668
There Are No Shortcuts: Electronic Health Record-Generated Tool Does Not Reflect Medication Adherence in Patients with SLEin Bronx, NY
- Abstract Number: 2206
There Is No Difference in Major Organ Involvement Andantibody Pattern Between Diffuse and Limited Subtypejuvenile Onsetsystemic Scleroderma Patients
- Abstract Number: 0371
This Is Caring: Enhancing Patient Education Materials for Individuals with Morphea Through Qualitative Inquiry
- Abstract Number: 2506
THP1-derived Macrophage Polarization in Takayasu Arteritis – Impact of Disease Status and Therapy
- Abstract Number: 0846
Three Novel Metabolomic Signatures of Inflammation for Female Gout Risk: A Prospective Cohort Study over 26 Years
- Abstract Number: 1977
Three-dimensional Stereophotogrammetry Has Utility in Tracking Upper Eyelid Involvement and Overall Disease Worsening in Patients with Craniofacial Localized Scleroderma
- Abstract Number: 1524
Thrombocytopenia and Systemic Lupus Erythematosus: A Meta-analysis of Observational Studies
- Abstract Number: 2680
Thrombocytopenia in Patients with Systemic Lupus ErythematosusReal-World Data Based on a Nationwide Database, RISE
- Abstract Number: 1039
Through the LuCIN Lens: Defining Barriers and Forging Solutions for Lupus Clinical Trials in North America
- Abstract Number: 1857
Thymic Mimetic Cells in Humans, Mice and Fish Are Evolutionarily Ancient with Species-specific Adaptations
- Abstract Number: 2464
Thymic Size Longitudinal Changes on Chest High-resolution Computed Tomography After Autologous Hematopoietic Stem Cell Transplantation for Diffuse Cutaneous Systemic Sclerosis
- Abstract Number: 0589
Time to Clinical Response to Secukinumab Across Disease Domains Among Patients with Psoriatic Arthritis: A Pooled Post Hoc Analysis of 4 Phase 3 Trials
- Abstract Number: 1467
Time to First Clinically Meaningful Efficacy Responses in Musculoskeletal and Patient Reported Outcomes in Patients with Active Psoriatic Arthritis Treated with Risankizumab: A Post Hoc Analysis of the Phase 3 KEEPsAKE 1 and KEEPsAKE 2 Trials
- Abstract Number: 1209
Time to Knee Replacement by Kellgren-Lawrence Grade and Presence of Frequent Knee Pain in Two Large and Diverse Longitudinal Cohorts: Data from MOST and OAI
- Abstract Number: 2273
Time-Trends in Real-World Glucocorticoid Treatment Strategies in Patients with Early Rheumatoid Arthritis: Results from the Canadian Early Arthritis Cohort(CATCH) Study
- Abstract Number: 2676
Timeframe for Initiating Methotrexate and Vaccine Response Against Pneumococcus in Rheumatoid Arthritis: The VACIMRA Study
- Abstract Number: 1940
Timely Initiation of Steroid Sparing Therapy in Uveitis Patients – a Quality Improvement Initiative
- Abstract Number: 1935
Timely Referral of Patients with Inflammatory Rheumatic Diseases to Rheumatology: Validation of a Referral Algorithm with Frontline Physicians
- Abstract Number: 1492
Timing of SLEDAI-2K Item Improvements During the First Year of Intravenous Anifrolumab Treatment of Moderate to Severe SLE
- Abstract Number: 0946
Tissue Resident Monocyte-lineage Cells (TR-MC) Exist as Two Different Subpopulations
- Abstract Number: 2338
TNF Inhibitor Therapy Increases Absolute Lymphocyte Count Which Is Associated with Lower Mortality in Patients with Psoriatic Arthritis
- Abstract Number: 0302
TNFAIP3 Loss-of-function and Missense Mutations Demonstrate Clinically Diverse Presentations: A Multi-center Cohort Experience
- Abstract Number: 1960
To Biopsy or Not to Biopsy: Imaging Features of Chronic Nonbacterial Osteomyelitis of the Clavicle
- Abstract Number: 1507
To Develop a Method for Estimating Interferon Signatures in SLE from Routine Clinical Laboratory Tests
- Abstract Number: 0459
Tocilizumab Demonstrates Superior Inhibition of MMP-Mediated Basement Membrane Collagen Degradation Compared to Methotrexate or Placebo
- Abstract Number: 1378
Tocilizumab Effect on the Three Pathways of the Complement System in Patients with Rheumatoid Arthritis
- Abstract Number: 1628
Tocilizumab for Giant Cell Arteritis in Japan over 2 Years: A Multicenter Retrospective Study
- Abstract Number: 0765
Tocilizumab in Extracranial Large-Vessel Giant Cell Arteritis and Takayasu Arteritis: A Multicentric Observational Comparative Study
- Abstract Number: 0745
Tocilizumab in Monotherapy vs. Combined in Aortitis Associated with Giant Cell Arteritis. Multicenter Open-label Study of 196 Patients
- Abstract Number: 0074
Tofacitinib Therapy Ameliorates Inflammation in a Mouse Model of Psoriasis and Arthritis by Inducing Type 2 Immunity
- Abstract Number: 0237
Tofacitinib: A Retrospective Study on Safety and Adverse Effects
- Abstract Number: 1769
Top Peripheral Blood Transcriptomic Gene Modules Reveal Functional Annotation and Correlation with Clinical Traits in Juvenile Dermatomyositis (JDM) and Myositis-Specific Autoantibody (MSA) Groups
- Abstract Number: 1010
Total Cost Risk Scores and Barrier Categories in Patients with Axial Spondyloarthritis and Associated Factors
- Abstract Number: 1260
Toward a Treat-to-target Strategy in Juvenile Dermatomyositis: Seeking for Suitable Targets and Optimal Timing of Their Achievement
- Abstract Number: 2128
Trabecular Bone Score Curve from a Qatari Population, Data from Qatar Biobank
- Abstract Number: 2185
TRACER: Transition to Adulthood Through Coaching and Empowerment in Rheumatology, a Feasibility Study
- Abstract Number: 1494
Trajectories of Disease Evolution upon Treatment Initiation in Systemic Lupus Erythematosus: Pooled Results from Three Randomized Clinical Trials of Belimumab
- Abstract Number: 2571
Trajectories of Physical Function in Children with Juvenile Idiopathic Arthritis: Results from the CAPRI Registry
- Abstract Number: 2536
Trans-Disease Microbial Biomarkers of Protection and Pathogenesis in Autoimmune Conditions: Results from the AMP AIM Consortium
- Abstract Number: 0940
Trans-endothelial Migration of Synovial Fibroblasts Promotes Arthritis Severity Through a PKD1-mediated Feedback Loop
- Abstract Number: 0024
Trans-Signaling by Soluble CD14 Sensitizes Chondrocytes to Lipopolysaccharide Stimuli, Increasing Chondrocyte Inflammatory Responses
- Abstract Number: 0763
Transcriptional Analysis of Both Normal and Abnormal TABs in Biopsy-proven GCA Reveals a Shared Gene Expression Profile Compared to Clinically Diverse Controls
- Abstract Number: 1836
Transcriptional Changes in the Formation of Tissue Resident Memory T Cells in the Joint
- Abstract Number: 0967
Transcriptional Heterogeneity of Immune Cells in the Esophagus of Systemic Sclerosis Patients: A Comparison of Upper and Lower Esophageal Regions
- Abstract Number: 1712
Transcriptome Analysis Characterizes the Role of Monocytes in Ankylosing Spondylitis with TNF-blocker Treatment
- Abstract Number: 0521
Transcriptome Analysis of Drug Response in a Large Cohort of Immune-Mediated Inflammatory Disease Patients Supports Advanced Combination Therapy in Rheumatoid Arthritis
- Abstract Number: 2691
Transcriptomic Changes in CD4+ T Lymphocytes in Eosinophilic Granulomatosis with Polyangiitis
- Abstract Number: 0022
Transcriptomic Characterization of Knee Capsule Fibroblasts and Mesenchymal Stromal Cells Reveals an Association Between Flexion Contracture and Alterations in Immune Pathways in People with End-stage OA
- Abstract Number: 2692
Transcriptomic Profiling of Kidney Biopsies Implicates Th17 and IL-17 in ANCA-Associated Vasculitis
- Abstract Number: 2634
Transcriptomic Stratification Predicts Response to Rituximab, Abatacept or the Association of Hydroxychloroquine and Leflunomide in 3 Randomized Controlled Clinical Trials in Sjögren’s Disease
- Abstract Number: 0622
Translation, Adaptation and Validation of the Brazilian-Portuguese Systemic Lupus Erythematosus Disease Activity Score (SLE-DAS) Version: Partial Results from a Single Centre
- Abstract Number: 1707
TRBV9-Targeted Bispecific T Cell-Engaging Antibodies to Reset the Autoreactive T Cell Compartment in Spondyloarthritis and HLA-DQ8 Celiac Disease
- Abstract Number: 2215
Treat (Depression to Reach)-to-Target in Rheumatoid Arthritis
- Abstract Number: 2016
Treat to Target in Gout Yields Superior Outcomes Compared to Treat to Avoid Symptoms Approach (results from the Gout TrEatment Strategy Overture Trial)
- Abstract Number: 1457
Treat-to-Target Approaches in Early Psoriatic Arthritis: Early Secukinumab versus Standard Care – 12- and 24-Week Results from a Multicenter, Open-Label, Randomized Controlled Trial
- Abstract Number: 0753
Treatment and Evolution in 134 Patients with Aortitis and Periaortitis. Experience of a Single Referral Centre
- Abstract Number: 2610
Treatment Concordance of Asynchronous Virtual Visits Compared to Traditional In-person Visits in Patients with Rheumatoid Arthritis: Results of the Prospective, Multi-center, Randomized Controlled TELERA Trial
- Abstract Number: 1194
Treatment Effect of Lorecivivint Across Multiple Trials in Patients with Knee OA: A Meta-analysis
- Abstract Number: 2346
Treatment Effect on Predictors of Ankylosis in Axial Spondyloarthritis
- Abstract Number: 0390
Treatment Effectiveness Following Switching from Initial TNF Inhibitor in Juvenile Idiopathic Arthritis
- Abstract Number: 2093
Treatment of Advanced Knee OA with Lorecivivint Leads to Improved Long-Term Patient Acceptable Symptom State (PASS) Compared to Placebo: Data from Phase 3 Extension Trial
- Abstract Number: 0736
Treatment of IgG4-Related Disease (IgG4-RD) with Elotuzumab, an Inhibitor of SLAM-F7: Report of a Phase 2 Clinical Trial
- Abstract Number: 2491
Treatment Outcomes of Eosinophilic Granulomatosis with Polyangiitis (EGPA):A Retrospective Analysis of US Health Insurance Claims Data
- Abstract Number: 1119
Treatment Outcomes of TNF-α Inhibitors in Cardiac Sarcoidosis
- Abstract Number: 0345
Treatment Patterns and Glucocorticoid Burden of Dermatomyositis Patients: A Cohort Study in the University of Pittsburgh’s Myositis Registry
- Abstract Number: 0663
Treatment Patterns and the Prevalence of Kidney Biopsy-Confirmed LN in Patients with SLE and Proteinuria: A Multicenter Cohort Study
- Abstract Number: 1454
Treatment Patterns, Clinical Characteristics, and Patient-Reported Outcomes Among Patients with Axial Spondyloarthritis Treated in Real-World Rheumatology Practices in the US
- Abstract Number: 1691
Treatment Response Biomarkers for Systemic Sclerosis-Associated Interstitial Lung Disease
- Abstract Number: 2231
Treatment Response over the First 6 Months in Newly Diagosed RA Patients by Pain, Anxiety, Depression & Fatigue (PADF) Symptom Clusters: Results from the Canadian Early Arthritis Cohort
- Abstract Number: 1845
Treg Expansion and IL-6 Induced STAT3 Phosphorylation in CD4+ T Cells Is a Biomarker of Disease Flare in Rheumatoid Arthritis
- Abstract Number: 1523
Trend Analysis of Lupus Nephritis Flares, Mortality, and Disparities: 2016-2020
- Abstract Number: 0998
Trends and Disparities in Cardiovascular Deaths in Systemic Lupus Erythematosus: A Population-Based Retrospective Study in the United States from 1999 to 2021
- Abstract Number: 2621
Trends in Disease Activity in Rheumatoid Arthritis over 2009-2023 Utilizing DAS28-CRP Inferred from Electronic Health Records
- Abstract Number: 2421
Trends in Glucocorticoid Use in Systemic Lupus Erythematosus in a Population-Based Inception Cohort from 1976 to 2018: The Lupus Midwest Network
- Abstract Number: 0509
Trends in Initiation of Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis Among Commercially-Insured US Adults, 2001-2021
- Abstract Number: 0280
Trends in Management and Consultations for Gout: A Study of 18 Million Adults Using the OpenSAFELY Platform
- Abstract Number: 0397
Trends in New Use of Disease-Modifying Antirheumatic Drugs in Juvenile Idiopathic Arthritis Among Commercially Insured Children in the United States from 2001-2022
- Abstract Number: 1877
Trends in Rheumatoid Arthritis Incidence, Prevalence, DALY and Death Rates (1991-2021) in the United States: A Comprehensive Analysis of State-Level Disparities
- Abstract Number: 0625
Trends, Outcomes, and Predictors of Mortality in Patients with SLE Hospitalized for Influenza
- Abstract Number: 2167
Trust and Shared Decision-Making in Adolescents with Systemic Lupus Erythematosus: Findings from a Pilot Survey Design Study
- Abstract Number: 0650
Tubulointerstitial Inflammation Predicts Tubular Atrophy, Fibrosis, and Renal Function Loss in Lupus Nephritis
- Abstract Number: 1349
Two Composite Cytokine Scores Predict Flare and Drug-free Remission in Patients with Rheumatoid Arthritis
- Abstract Number: 2168
Two Year Data on Quality of Life, Pain and Mobility Scores After Rituximab Treatment in the Preclinical Phase of Rheumatoid Arthritis
- Abstract Number: 0381
Two- and 3-Year Outcomes of the Childhood Arthritis and Rheumatology Research Alliance FROST Study of New-onset Systemic JIA Treatment
- Abstract Number: 2612
Two-Week Methotrexate Discontinuation in Autoimmune Rheumatic Diseases Patients Vaccinated with Recombinant Herpes Zoster Vaccine: An Interim Analysis of a Prospective Randomized Phase 4 Study
- Abstract Number: 0862
Two-year’s Worsening of Semi-quantitative MRI Features as Surrogate Outcomes for Long-term Incident Radiographic Knee Osteoarthritis After ACL-rupture
- Abstract Number: 0001
Type I Interferon and Anifrolumab Effects on Bone Marrow and Blood Plasma Cells in Systemic Lupus Erythematosus
- Abstract Number: 2303
Type I Interferon Signature Drives Phenotypic Clusters of Sjögren’s Disease and Can Predict Systemic Evolution Among the “B-cell Active with Low Symptoms” Subgroup
- Abstract Number: 1497
Type I Interferon Status and Clinical Manifestations in a Large Cohort of Patients with Systemic Lupus Erythematosus
ACR Convergence 2024
November 14-19, 2024. Washington, DC.